Genetic Test prior to Radiation - Prostate Cancer N...

Prostate Cancer Network

3,316 members1,886 posts

Genetic Test prior to Radiation

chral11 profile image

Is a genetic test predictive of susceptibility to radiation therapy toxicity something that is recommended prior to starting ones therapy (SBRT)? What is this test anyway so I can ask my RO beforehand if indeed useful. Thanks.

10 Replies

A germline test will tell you if you have any rare inherited genetic diseases.

prostatecancer.news/2018/02...

A test of the genomics of your prostate biopsy may be useful if you are on active surveillance and considering getting treatment.

There are no genomic tests you need before primary therapy.

chral11 profile image
chral11 in reply to Tall_Allen

Thanks Allen as usual. I have noticed in reading different posts that UCLA's Amar Kishan does a genetic test prior to radiation treatment. I'm not sure if it is part of an ongoing study or a DNA test can help deciding how many fractions over what duration will be most effective while reducing side effects. I found this study on GARUDA:uclahealth.org/urology/iuo/...

I did get a Decipher test last month based on 5 month old biopsy. It was relatively low at 0.38 and within AS range. I'm still pursuing treatment though a soon as I find the right RO.

Tall_Allen profile image
Tall_Allen in reply to chral11

He is doing his own trial. He is hunting for genetic biomarkers that may predict optimum radiation schedules. He expects first results in 2027.

chral11 profile image
chral11 in reply to Tall_Allen

Got it. So he is not changing anybody's regimen outside established guidelines yet as a result of the test!

Thank you for your continued time and effort you devote to education on PCa.

Wondering if you take requests for blog articles - I'd sure like to see a writeup summarizing the various machines and tracking systems being used for SBRT, and if any have advantages over the others. Maybe include the older systems which are still in use, and potential new systems coming out.

Dr Kishan has a randomized trial now between their standard VMAT (Truebeam with rapidarc) and the 1.5T MRI-guided MRIdian. Personally, I doubt whether it makes a difference for primary treatment, but we'll see. I expect there will be a difference for salvage radiation, but we'll see. The latest innovation is a PET-guided linac. Again, we'll see. The technology probably matters less than you would think.

chral11 profile image
chral11 in reply to Tall_Allen

Now that we've expanded this topic, can I ask your opinion Allen on PSMA scan? Do you think Pylarify PSMA PET/CT would add any value prior to initial treatment in Favorite Intermediate? Can the RO make any sense of the resulting image with a relatively high PSA? Or would the usual MRI be more useful?

Tall_Allen profile image
Tall_Allen in reply to chral11

No value for PSMA PET in fav. intermediate risk PCa. No diagnostic value for MRI either, just for planning.

chral11 profile image
chral11 in reply to Tall_Allen

I checked with UCLA about their MRIdian Viewray's resolution. They said it is 0.35T and not 1.5T, same as other MRIdians. The centers with a Viewray do their SBRT planning on the same machine. Is 0.35T resolution on a Viewray sufficient for SBRT planning? If the radiologist that looked at my 3T MPMRI misinterpreted it and it had to be reread, how can the RO looking at 0.35T pictures do a proper plan?

Tall_Allen profile image
Tall_Allen in reply to chral11

You are right - it is a 0.35T MRI at UCLA. Dr. Kishan assures me the resolution is adequate. He says it is the MRI gating that allows for tighter margins and potentially less toxicity. He is running an RCT to see if that is true. There is an Elekta Linac/MRI that uses 1.5T.

You may also like...